In our analysis, hsa‐miR‐15a‐5p was seen to target several genes, including known oncogenes and tumor suppressor genes such as CCND1, CDK6 and DICER1, thus suggesting biomarker potential also in LS. The gene discussed is CCND1; the disease is Leigh syndrome.